Tech Query: HDFC Bank, Eternal (Zomato), Dixon Technologies, Cohance Lifesciences (Suven Pharmaceuticals) – What Is The Outlook? Where Are These Stocks Headed? 

What is the outlook for HDFC Bank?

Tarun Dutta

HDFC Bank (₹931): The short-term picture is negative. The fall below ₹945 indicates a double-top bearish reversal pattern. Immediate support is at ₹915. A break below it will confirm this pattern. That in turn will increase the danger of seeing a fall to ₹890 or even ₹850 in the coming weeks. To avoid this fall, the stock must sustain above ₹915 and rise above ₹950 immediately in the next one or two weeks. From a long-term perspective, ₹850 is a strong support.

A fall below it is unlikely. We can expect the stock to reverse higher and resume the overall uptrend. This leg of rally will have the potential to take HDFC Bank share price up to ₹1,300 in a year or two. You may have to wait for a fall to buy the stock around ₹850.

What is the long-term outlook for Eternal (Zomato)? I have bought this stock at ₹320.

Jaya Rami Reddy

Eternal (₹288): The long-term trend is up. Within that, the stock is in a correction phase since October last year. There is not much room left of the downside. Strong supports are at ₹270 and then in the ₹255-250 region. A fall below ₹250 is less likely. A fresh leg of rally from around ₹250 will indicate the resumption of the broader uptrend.

That will have the potential to take Eternal (Zomato) share price up to ₹420 over the next one year or so. You can accumulate at ₹275 and ₹255. Keep the stop-loss at ₹215. Move the stop-loss up to ₹305 when the price goes up to ₹345. Revise the stop-loss higher to ₹340 and ₹375 when the price touches ₹370 and ₹395 respectively. Exit the stock at ₹415.

What is the outlook for Dixon Technologies?

Nakul Kumar

Dixon Technologies (₹10,732): The outlook is bearish. The stock has formed a bearish double top reversal pattern. The region between ₹12,800 and ₹12,900 will be a strong resistance zone. Moving average cross overs on the weekly chart also strengthens the bearish case. Any intermediate bounce can be capped at ₹12,800-12,900. A rise beyond ₹12,900 might be difficult and will need some strong positive triggers.

The double-top pattern target is coming around ₹6,100. Intermediate support is around ₹9,000 which can be tested in the next three months or so. A bounce from there will be short-lived. An eventual break above ₹9,000 will see the share price tumbling towards ₹6,100. It is better to stay out of this stock for now. You will have wait for the price to come down to ₹6,100 to enter into this stock.

I have Cohance Lifesciences (Suven Pharmaceuticals) shares. Should I continue to hold the stock or exit?

T Srikrishna, Bengaluru

Cohance Lifesciences (₹426): The stock has very limited data to do a detailed technical analysis.. However, we will try to give an overall view on this stock. You can take a call based on that. The trend is down and strong. There is no sign of a reversal. Resistances are at ₹520 and ₹600. The stock has to rise above ₹600 to get some breather.

However, to become bullish, the share price has to go above ₹850. Only then the upside will open up to revisit ₹1,000 and higher levels. As no major supports are visible on the chart (due to lack of historical data), the downside remains open. Since there is no sign of a reversal, it is better to exit the stock immediately.

Send your questions to techtrail@thehindu.co.in

Published on January 17, 2026